ALDH1B1 and hepatocellular carcinoma: Moreover, survival analyses have shown that high expression of ALDH1B1 in 212 HBV-related HCC patients had a favorable outcome in terms of overall survival (OS) (Fig 3A) and recurrence–free survival (RFS) (Fig 3B).